Related Experiment Video
Updated: Jan 23, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
[Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment]
Paolo Calabrò1, Felice Gragnano1, Arturo Cesaro1
1Divisione di Cardiologia Clinica Universitaria, AORN Sant'Anna e San Sebastiano, Caserta, e Dipartimento di Scienze Mediche Traslazionali, Università della Campania "Luigi Vanvitelli", Napoli.
Insights
Atrial fibrillation (AF) increases stroke risk by causing blood clots. Non-vitamin K antagonist oral anticoagulants (NOACs) are effective for prevention, but their role in dissolving existing clots requires further research.
Area of Science:
- Cardiology
- Thrombosis Research
- Pharmacology
Background:
- Atrial fibrillation (AF) is a growing cardiac arrhythmia linked to aging populations.
- AF increases the risk of thromboembolic events due to thrombus formation in the atria.
- Current treatments focus on anticoagulation to prevent clots, with NOACs offering safety advantages over warfarin.
Purpose of the Study:
- To review literature on atrial and left atrial appendage thrombosis.
- To describe pathophysiological mechanisms of thrombus formation in AF.
- To evaluate current treatment strategies for AF-related thrombosis, focusing on NOACs.
Main Methods:
- Literature review of studies on atrial fibrillation and thrombosis.
- Analysis of pathophysiological factors contributing to thrombus formation.
- Assessment of current and emerging therapeutic strategies, particularly NOACs.
Main Results:
- AF is a major risk factor for thromboembolic events.
- NOACs represent a safer alternative to warfarin for preventing atrial appendage thrombosis.
- The efficacy of NOACs in resolving existing thrombi is not well-established and requires further investigation.
Conclusions:
- AF-related thrombosis poses significant morbidity and mortality risks.
- NOACs are a key advancement in preventing atrial appendage thrombosis.
- Further research is needed to define the role of NOACs in thrombus resolution.
Abstract:
Atrial fibrillation (AF) is the most frequent sustained cardiac arrhythmia, and its prevalence is increasing, partly due to the progressive aging of the population. AF predisposes to thrombus formation in the atria and the atrial appendage through a complex interaction among local, systemic and hemodynamic factors, significantly increasing the risk for cerebral and systemic thromboembolic events. These complications have a major impact in terms of morbidity and mortality, and numerous therapeutic strategies have been proposed to reduce such risk. Systemic anticoagulation is the main strategy in the prevention of atrial and left atrial appendage thrombosis, and the advent of non-vitamin K antagonist oral anticoagulants (NOACs) has been a significant step forward, especially for safety, compared to warfarin. While prevention of atrial appendage thrombosis with NOACs has been widely explored, their role in the resolution of thrombi is less clear. The use of NOACs in this setting is largely unexplored, and some studies are underway to clarify their effectiveness. The objective of this paper is to review the literature on atrial and left atrial appendage thrombosis, describing pathophysiological mechanisms and current treatment strategies using NOACs.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Surface Appendages of Archaea
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...